{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:25Z","timestamp":1790688625241,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shenzhen Municipal Science and Technology Innovation Committee","award":["JCYJ20160428175626942"],"award-info":[{"award-number":["JCYJ20160428175626942"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.biopha.2019.109406","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T06:01:27Z","timestamp":1568008887000},"page":"109406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer"],"prefix":"10.1016","volume":"119","author":[{"given":"Shangwen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2019.109406_bib0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrurol.2014.194","article-title":"Landmarks in the diagnosis and treatment of renal cell carcinoma","volume":"11","author":"Bhatt","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109406_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11427-016-0297-2","article-title":"Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy, Science China","volume":"60","author":"Zheng","year":"2017","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2019.109406_bib0015","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1016\/S1470-2045(13)70569-2","article-title":"Radiotherapy for renal-cell carcinoma","volume":"15","author":"De Meerleer","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109406_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/CAD.0b013e3283609ec1","article-title":"Chemotherapy in metastatic renal cell carcinoma today? A systematic review","volume":"24","author":"Buti","year":"2013","journal-title":"Anti-Cancer Drugs"},{"issue":"10","key":"10.1016\/j.biopha.2019.109406_bib0025","first-page":"18861","article-title":"Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma","volume":"8","author":"Jin","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109406_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15586\/jkcvhl.2015.40","article-title":"MicroRNAs in clear cell renal cell carcinoma: biological functions and applications","volume":"2","author":"Aguiari","year":"2015","journal-title":"J. Kidney Cancer VHL"},{"issue":"3","key":"10.1016\/j.biopha.2019.109406_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12033-007-9013-8","article-title":"The microRNA (miRNA): overview of the RNA genes that modulate gene function","volume":"38","author":"Ying","year":"2008","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109406_bib0040","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3892\/mmr.2017.6829","article-title":"Oncogenic miR-23a-5p is associated with cellular function in RCC","volume":"16","author":"Quan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2019.109406_bib0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.biopha.2018.05.082","article-title":"Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma","volume":"105","author":"Zhou","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2019.109406_bib0050","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.juro.2014.07.001","article-title":"Expression of the tumor suppressive miRNA-23b\/27b cluster is a good prognostic marker in clear cell renal cell carcinoma","volume":"192","author":"Ishihara","year":"2014","journal-title":"J. Urol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109406_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/gm272","article-title":"MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer","volume":"3","author":"Shah","year":"2011","journal-title":"Genome Med."},{"issue":"7","key":"10.1016\/j.biopha.2019.109406_bib0060","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/bjs.6628","article-title":"MicroRNAs are novel biomarkers of colorectal cancer","volume":"96","author":"Aslam","year":"2009","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.biopha.2019.109406_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1479-5876-10-119","article-title":"High level of miR-221\/222 confers increased cell invasion and poor prognosis in glioma","volume":"10","author":"Zhang","year":"2012","journal-title":"J. Transl. Med."},{"issue":"7456","key":"10.1016\/j.biopha.2019.109406_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"N. Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2019.109406_bib0075","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.juro.2013.12.046","article-title":"Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: united States 2001 to 2010","volume":"191","author":"King","year":"2014","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.biopha.2019.109406_bib0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.urolonc.2015.10.003","article-title":"Surgical considerations for patients with metastatic renal cell carcinoma","volume":"33","author":"Adibi","year":"2015","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109406_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11255-012-0374-y","article-title":"Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma","volume":"45","author":"Wang","year":"2013","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109406_bib0090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/cam4.631","article-title":"MicroRNA-194 is a marker for good prognosis in clear cell renal cell carcinoma","volume":"5","author":"Nofech-Mozes","year":"2016","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109406_bib0095","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.3892\/ol.2017.6809","article-title":"MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer","volume":"14","author":"Hou","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2019.109406_bib0100","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.2147\/OTT.S147974","article-title":"Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer","volume":"10","author":"Li","year":"2017","journal-title":"OncoTargets Ther."},{"issue":"16","key":"10.1016\/j.biopha.2019.109406_bib0105","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1158\/1078-0432.CCR-09-0092","article-title":"MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality","volume":"15","author":"Gramantieri","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109406_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2407-10-367","article-title":"MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN","volume":"10","author":"Chun-Zhi","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2019.109406_bib0115","first-page":"5224","article-title":"miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma","volume":"8","author":"Lu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109406_bib0120","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1007\/s13277-013-1531-3","article-title":"Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients","volume":"35","author":"Teixeira","year":"2014","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.biopha.2019.109406_bib0125","doi-asserted-by":"crossref","first-page":"e109877","DOI":"10.1371\/journal.pone.0109877","article-title":"Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava","volume":"9","author":"Vergho","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2019.109406_bib0130","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/mt.2015.129","article-title":"miR-221\/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma","volume":"23","author":"Khella","year":"2015","journal-title":"Mol. Ther."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219312648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219312648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T11:05:53Z","timestamp":1731409553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219312648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":26,"alternative-id":["S0753332219312648"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109406","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109406"}}